NCT02064920View on ClinicalTrials.gov

Computerized Cognition Testing in Participants With Mild Alzheimer's Disease (AD) Treated With Donepezil (MK-0000-318)

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 22, 2014

Primary Completion Date

July 13, 2016

Study Completion Date

July 13, 2016

Conditions
Alzheimer's Disease
Interventions
DRUG

Placebo

Placebo for donepezil hydrochloride capsule

DRUG

Donepezil

5 mg donepezil hydrochloride capsule.

DRUG

Donepezil

10 mg donepezil hydrochloride capsule.

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT02064920 - Computerized Cognition Testing in Participants With Mild Alzheimer's Disease (AD) Treated With Donepezil (MK-0000-318) | Biotech Hunter | Biotech Hunter